申请人:Janssen BioPharma, Inc.
公开号:US11312727B1
公开(公告)日:2022-04-26
The present invention relates to macrocyclic pyridotriazine derivatives of formula (I) and the pharmaceutically acceptable salts, solvates or polymorph thereof, and the use of such compounds as a medicament, in particular in the prevention and/or treatment of viral infections caused by viruses belonging to the Orthomyxoviridae family. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the compounds, and to the compositions or preparations for use as a medicament, more preferably for the prevention or treatment of viral infections caused by viruses belonging to the Orthomyxoviridae family.
本发明涉及式(I)的大环哒嗪衍生物及其药学上可接受的盐、溶解物或多晶型物,以及此类化合物作为药物的用途,特别是用于预防和/或治疗由属于正粘病毒科的病毒引起的病毒感染。本发明还涉及化合物的药物组合物或组合制剂,以及用作药物的组合物或制剂,更优选用于预防或治疗由属于Orthomyxoviridae科的病毒引起的病毒感染。